Literature DB >> 9973033

Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction.

S C Smart1, P N Dionisopoulos, T A Knickelbine, T Schuchard, K B Sagar.   

Abstract

OBJECTIVE: To assess the prognostic value of sustained improvement, scar and inducible ischemia with or without viability in patients with chronic left ventricular dysfunction (LVD).
BACKGROUND: Dobutamine-atropine stress echocardiography (DASE) accurately detects scar, reversible dysfunction and the extent of coronary artery disease in LVD.
METHODS: Three hundred fifty consecutive patients (age 62+/-13 years, mean+/-SD, 215 men/135 women) with moderate to severe LVD (LVEF < 40%, mean 30+/-8%) underwent DASE and were followed for > or =18 months. Dobutamine-atropine stress echocardiographic findings were classified according to sustained improvement in all vascular territories, scar, inducible ischemia (worsening wall motion at peak dose only or biphasic responses) and their extent.
RESULTS: Sustained improvement occurred in 83 patients (24%), scar alone in 99 (28%) and inducible ischemia in 168 (48%, with biphasic responses in 104). Ischemia was induced in all vascular territories in 26 patients. Patients with sustained improvement or scar alone were treated medically, whereas 46% (78/168) with inducible ischemia were revascularized (coronary bypass surgery, n = 67 or angioplasty, n = 11). There were 76 hard events including cardiac death in 59, nonfatal myocardial infarction in 11, and resuscitated sudden death in 6. Hard events were rare in sustained improvement (5%, 4/83), uncommon in scar (13%, 13/99) and common (p < 0.01) in medically treated patients with inducible ischemia (59%, 53/90). Cardiac deaths were especially common (p < 0.01) in patients with biphasic responses (55%, 28/51). Inducible ischemia independently predicted hard events (chi2 = 75.35, p < 0.001) along with reduced LVEF at peak dose (chi2 = 8.38, p = 0.004). Hard cardiac events were uncommon (8%, 6/78, p < 0.001) in patients with inducible ischemia who underwent early revascularization.
CONCLUSIONS: Inducible ischemia during DASE was the major determinant of outcome in LVD and independent of clinical data and left ventricular function. Improved wall thickening alone and scar alone predicted good outcome. Survival of patients with inducible ischemia was better after revascularization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973033     DOI: 10.1016/s0735-1097(98)00594-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  Post-myocardial infarction risk stratification with stress nuclear myocardial perfusion imaging versus echocardiography: separate but not equal.

Authors:  K A Brown
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

Review 2.  Stress echocardiography in the diagnosis of coronary artery disease.

Authors:  W Mazur; S F Nagueh
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

3.  Quantity of viable myocardium required to improve survival with revascularization in patients with ischemic cardiomyopathy: A meta-analysis.

Authors:  Yoichi Inaba; Jennifer A Chen; Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2010-04-09       Impact factor: 5.952

Review 4.  Hibernating myocardium.

Authors:  John M Canty; James A Fallavollita
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

5.  Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation.

Authors:  V Rizzello; D Poldermans; A F L Schinkel; E Biagini; E Boersma; A Elhendy; F B Sozzi; A Maat; F Crea; J R T C Roelandt; J J Bax
Journal:  Heart       Date:  2005-04-06       Impact factor: 5.994

Review 6.  Stress echocardiography for the detection and assessment of coronary artery disease.

Authors:  Nowell M Fine; Patricia A Pellikka
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

7.  Evaluating left ventricular systolic dysfunction: Stress echocardiography.

Authors:  Edgar Argulian; Farooq A Chaudhry
Journal:  J Nucl Cardiol       Date:  2015-07-08       Impact factor: 5.952

8.  Left ventricular cavity obliteration during dobutamine stress echocardiography in diabetic patients.

Authors:  Francesca Innocenti; Caterina Baroncini; Chiara Agresti; Edoardo Mannucci; Matteo Monami; Riccardo Pini
Journal:  Int J Cardiovasc Imaging       Date:  2011-07-06       Impact factor: 2.357

Review 9.  Noninvasive assessment myocardial viability: current status and future directions.

Authors:  Kevin C Allman
Journal:  J Nucl Cardiol       Date:  2013-06-15       Impact factor: 5.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.